ClinicalTrials.Veeva

Menu

Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Klebsiella Pneumoniae Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT04337840
202003047RINA

Details and patient eligibility

About

Nosocomial infections are increasing rapidly both internationally and domestically, especially carbapenem-resistant Klebsiella pneumoniae infections. However, there were still lack of evidence about the risk and prognosis in Taiwan. The choice of drug and related sensitivity test was also limited. We would analyze the infection risk, prognosis, and drug sensitivity of Klebsiella pneumoniae and focus on strategy to manage carbapenem-resistant Klebsiella pneumoniae infections.

Enrollment

200 estimated patients

Sex

All

Ages

21 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

All adult patients (≥18 years) with K. pneumoniae bloodstream infection were included. Patients were excluded if there was other recognized bacteremia within two weeks before or after the first episode of K. pneumoniae bloodstream infection.

Trial contacts and locations

1

Loading...

Central trial contact

Jen-Yu Hsu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems